Clinical Trials Browser

Phase 1 × Hodgkin Disease × plerixafor × Clear all

NCT02343666 2018-11-20

HIV-Resistant Gene Modified Stem Cells and Chemotherapy in Treating Patients With Lymphoma With HIV Infection

Phase 1 Withdrawn

Hodgkin Disease, Lymphoma, Non-Hodgkin